Our Perspectives

Cerberus Ventures partners with visionary founders and consequential companies looking to move the world forward.
No items found.
Filter by:
Category
Link Template
Clear selection
General
Winning the AI Race
Creating Energy and Resource Resilience
Securing Essential Infrastructure
Unlocking Compute Abundance
Catalyzing the Bio Era
Video
News
Perspectives
Thank you!
Your submission has been received!
Oops! Something went wrong while submitting the form.
Bio
News
2 min
Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service
Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today announced that it has closed $45.2 million and secured commitments for an additional $9.2 million as part of an oversubscribed series B financing round.
Read
General
Perspectives
Beyond Success: Striving for Significance
Nearly 30 years ago, I spent the day with a man named Ron Robinson. He was a renowned communications strategist with a resume that included advising U.S. Presidents and many other leaders.
Read
General
Perspectives
An Architectural Approach to Shaping the Future
The ocean covers approximately 70% of the earth’s surface. It regulates the climate, supports more than 80% of the planet’s biodiversity, and powers international commerce. In many ways, it is the lifeblood of the global economy.
Read
General
Perspectives
Investing Early in Bold Missions
We are living in a time of profound global shifts. Geopolitical currents are reshaping supply chains and alliances. Technology is redefining what’s possible across nearly every sector.
Read
Compute
News
Maybell Quantum Secures $40 Million Series B Led by Addition to Accelerate Next-Generation Quantum Infrastructure to Market
Maybell Quantum, The Quantum Infrastructure Company, today announced a $40 million Series B financing round led by Addition.
Read
Bio
News
Syntis Bio Closes $38 Million Financing to Accelerate Oral Therapies for Obesity and Rare Diseases
Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes and rare diseases, announced today the close of a $33 million oversubscribed Series A financing.
Read
Compute
News
Lightsynq Acquired by IonQ
Integration of Lightsynq’s photonic interconnect and quantum memory technologies accelerates IonQ’s roadmap toward scalable, fault-tolerant quantum systems
Read
Energy
News
DG Matrix Raises $20 Million to Revolutionize Global Energy Infrastructure
DG Matrix, the developer of the revolutionary Power Router platform, secured $20 million in an oversubscribed seed funding round to accelerate the commercialization of its solid-state transformer solutions for the electrification of industry and AI-driven data center markets.
Read
Compute
News
The Crystal Ball: What 2025 holds for pivotal sectors, including crypto, consumer, and health
"2025 could be a year of awakening for quantum computing as more awareness emerges around its potential to deliver positive impacts across vast applications." —Morgan Mahlock
Read
Compute
News
Lightsynq Raises Series A Led by Cerberus Ventures
Lightsynq Technologies Inc., a startup developing quantum interconnect technology solutions for commercial use, today announced it has raised approximately $18 million in Series A funding.
Read
Compute
Video
Maybell: Making Quantum Possible
If you have trouble grasping the difference between quantum computing and traditional computing, you're not alone.
Read
Compute
News
Maybell Quantum Announces Series A Funding
Maybell Quantum (“Maybell”), the quantum infrastructure company, has closed a $25 million funding round led by an affiliate of Cerberus Capital Management, L.P. (“Cerberus”), a global leader in alternative investing.
Read

No Results Found

Try adjusting your search

We dive deep into critical topics, fast.
Hear what we see significantly shaping the future.

meet our people
quick links
Approach
Focus
Portfolio
People
Perspectives
Connect
Legal
Privacy Policy
Terms & Conditions
©  Cerberus. All rights reserved.
Footnotes
Disclaimer
Information included herein represents the views and beliefs of Cerberus. There can be no guarantee Cerberus Ventures will achieve its investment objectives or that partnering with Cerberus Ventures will ensure or contribute to the success of any company. For more information about Cerberus, please visit www.cerberus.com.

By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

PreferencesRejectAccept
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.